Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Grifols, S.A.

Clinical Briefings™: New Frontiers in Alpha-1 Antitrypsin Deficiency – Analyzing Diagnosis and the Efficacy of Available Therapies

Release Date: June 11, 2020
Expiration Date: June 11, 2021

Activity Overview

This online activity is designed to provide a concise and focused overview of the pathophysiology of α1-antitrypsin deficiency (AATD), the clinical presentation and diagnostic evaluation of patients with this condition, and the efficacy and safety of therapies recommended for the management of pulmonary complications. The multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Grifols, S.A.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This online educational activity is directed toward pulmonologists, primary care physicians, critical care specialists, and other health care providers involved in the management of patients with pulmonary disease.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Discuss the genotypic and phenotypic variations in AATD
  • Review clinical, laboratory, and genotype testing in the evaluation of patients with AATD
  • Evaluate the efficacy and safety of augmentation therapy and pulmonary management in the care of patients with AATD

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Timothy Craig, DO
Timothy Craig, DO
Professor of Medicine, Pediatrics, and Graduate Studies
Director of Clinical Research, Allergy, Asthma, and Immunology Center
Director, Alpha-1 Foundation Clinical Resource Center
Penn State University
Hershey, PA

Disclosures: Grant Research Support: CSL Behring, Takeda Pharmaceutical Co Ltd, Grifols SA; Consultant: CSL Behring, Takeda Pharmaceutical Co Ltd, Grifols SA; Other: CME Grant Takeda Pharmaceutical Co Ltd.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By